Cargando…
Targeting KRAS in PDAC: A New Way to Cure It?
SIMPLE SUMMARY: Pancreatic cancer is one of the most intractable malignant tumors worldwide, and is known for its refractory and poor prognosis. Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. KRAS is the most commonly mutated oncogene in PDAC. It has been consi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599866/ https://www.ncbi.nlm.nih.gov/pubmed/36291766 http://dx.doi.org/10.3390/cancers14204982 |